HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Fludarabine therapy in a patient with progressive symptomatic Waldenström's macroglobulinemia.

Abstract
A 66-year old female patient with symptomatic Waldenström's macroglobulinemia was treated with six courses of fludarabine monophosphate, which resulted in partial remission of the disease. Six months after completion of therapy IgM level decreased further and durable partial remission was confirmed.
AuthorsK Hałaburda, A Hellmann
JournalActa haematologica Polonica (Acta Haematol Pol) Vol. 25 Issue 1 Pg. 63-7 ( 1994) ISSN: 0001-5814 [Print] Poland
PMID8209618 (Publication Type: Case Reports, Journal Article)
Chemical References
  • Antineoplastic Agents
  • Hemoglobins
  • Immunoglobulin M
  • Vidarabine
  • fludarabine
Topics
  • Antineoplastic Agents (therapeutic use)
  • Female
  • Follow-Up Studies
  • Hemoglobins (analysis)
  • Humans
  • Immunoglobulin M (blood)
  • Middle Aged
  • Remission Induction
  • Vidarabine (analogs & derivatives, therapeutic use)
  • Waldenstrom Macroglobulinemia (blood, drug therapy)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: